These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24960297)

  • 1. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina.
    Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY
    Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
    Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
    J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization.
    Nie Y; Ji L; Ding H; Xie L; Li L; He B; Wu Y; Gu Z
    Theranostics; 2012; 2(11):1092-103. PubMed ID: 23227125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical stability of cholesterol derivatives combined with liposomes and their in vitro behavior.
    Yang B; Geng SY; Wang JY
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4114-7. PubMed ID: 24110637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N
    Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
    Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
    J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior.
    Li Y; Liu R; Yang J; Shi Y; Ma G; Zhang Z; Zhang X
    Biomaterials; 2015 Feb; 41():1-14. PubMed ID: 25522960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.
    Jiang W; Lionberger R; Yu LX
    Bioanalysis; 2011 Feb; 3(3):333-44. PubMed ID: 21320053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
    Boakye CH; Patel K; Singh M
    Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition.
    Kopecka J; Salzano G; Campia I; Lusa S; Ghigo D; De Rosa G; Riganti C
    Nanomedicine; 2014 Jan; 10(1):77-87. PubMed ID: 23850894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.